These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32537333)

  • 1. OnabotulinumtoxinA Treatment for Moderate to Severe Forehead Lines: A Review.
    De Boulle K; Carruthers A; Solish N; Carruthers J; Phillipp-Dormston WG; Fagien S; Sangha S; Silberberg M; Mao C
    Plast Reconstr Surg Glob Open; 2020 Mar; 8(3):e2669. PubMed ID: 32537333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, Patient-Reported Outcomes, and Safety in Male Subjects Treated With OnabotulinumtoxinA for Improvement of Moderate to Severe Horizontal Forehead Lines.
    Keaney TC; Cavallini M; Leys C; Rossi A; Drinkwater A; Manson Brown S; Garcia JK; Mao C
    Dermatol Surg; 2020 Feb; 46(2):229-239. PubMed ID: 31343446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines.
    De Boulle K; Werschler WP; Gold MH; Bruce S; Sattler G; Ogilvie P; Street J; Larsen KE; Yushmanova I; Lei X; Lee E; Vitarella D; Mao C
    Dermatol Surg; 2018 Nov; 44(11):1437-1448. PubMed ID: 30096106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, Patient-Reported Outcomes, and Safety for Millennial Subjects Treated With OnabotulinumtoxinA for Moderate to Severe Horizontal Forehead Lines.
    Palm MD; Few J; Patel T; Safa M; Drinkwater A; Mao C; Garcia JK
    Dermatol Surg; 2020 May; 46(5):653-661. PubMed ID: 31625954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of OnabotulinumtoxinA Treatment of Forehead Lines: A Multicenter, Randomized, Dose-Ranging Controlled Trial.
    Solish N; Rivers JK; Humphrey S; Muhn C; Somogyi C; Lei X; Bhogal M; Caulkins C
    Dermatol Surg; 2016 Mar; 42(3):410-9. PubMed ID: 26863598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forehead Line Treatment With OnabotulinumtoxinA in Subjects With Forehead and Glabellar Facial Rhytids: A Phase 3 Study.
    Fagien S; Cohen JL; Coleman W; Monheit G; Carruthers J; Street J; Larsen KE; Yushmanova I; Lei X; Lee E; Vitarella D; Mao C
    Dermatol Surg; 2017 Dec; 43 Suppl 3():S274-S284. PubMed ID: 33065953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants: A meta-analysis.
    Brin MF; De Boulle K; Liew S; Carruthers A; Carruthers J; Rivkin A; Wu Y; Kawashima M; Yushmanova I; Boodhoo TI; Lee E
    JAAD Int; 2024 Mar; 14():4-18. PubMed ID: 38035126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of crow's feet lines and forehead lines with Botox (onabotulinumtoxinA): Development, insights, and impact.
    Carruthers A; Carruthers J; De Boulle K; Lowe N; Lee E; Brin MF
    Medicine (Baltimore); 2023 Jul; 102(S1):e32496. PubMed ID: 37499083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OnabotulinumtoxinA for Simultaneous Treatment of Upper Facial Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Study.
    Rivkin AZ; Ogilvie P; Dayan S; Yoelin SG; Weichman BM; Garcia JK
    Dermatol Surg; 2020 Jan; 46(1):50-60. PubMed ID: 30829771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Patient Satisfaction for up to 6 Months With OnabotulinumtoxinA Treatment for Upper Facial Lines.
    Cohen JL; Fagien S; Ogilvie P; De Boulle K; Carruthers J; Cox SE; Kelly R; Garcia JK; Sangha S
    Dermatol Surg; 2022 Nov; 48(11):1191-1197. PubMed ID: 36342250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines.
    Carruthers J; Rivkin A; Donofrio L; Bertucci V; Somogyi C; Lei X; Davis PG; Campo A; Beddingfield FC
    Dermatol Surg; 2015 Jun; 41(6):702-11. PubMed ID: 25993609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial.
    Moers-Carpi M; Carruthers J; Fagien S; Lupo M; Delmar H; Jones D; Somogyi C; Lee E; Lei X; MacKinnon S; Davis PG; Yalamanchili R; Campo A; Beddingfield FC
    Dermatol Surg; 2015 Jan; 41(1):102-12. PubMed ID: 25485803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OnabotulinumtoxinA for Treatment of Forehead and Glabellar Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Double-Blind Study.
    Ogilvie P; Rivkin AZ; Dayan S; Yoelin SG; Weichman BM; Garcia JK
    Dermatol Surg; 2019 May; 45(5):689-699. PubMed ID: 31034447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A for facial wrinkles.
    Camargo CP; Xia J; Costa CS; Gemperli R; Tatini MD; Bulsara MK; Riera R
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011301. PubMed ID: 34224576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
    Rzany BJ; Ascher B; Avelar RL; Bergdahl J; Bertucci V; Bodokh I; Carruthers JA; Cartier H; Delmar H; Denfeld R; Gross JE; Heckmann M; Hedén P; Hilton S; Inglefield C; Ogilvie P; Sattler G; Sebastian M; Solish N; Swift A; Trévidic P
    Aesthet Surg J; 2020 Mar; 40(4):413-429. PubMed ID: 30951166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
    Wu Y; Fang F; Lai W; Li C; Li L; Liu Q; Lu J; Pang X; Sun J; Shi X; Picaut P; Prygova I; Andriopoulos B; Sun Q
    Aesthetic Plast Surg; 2023 Feb; 47(1):351-364. PubMed ID: 36536093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: a meta-analysis of individual patient data from global clinical registration studies in 1678 participants.
    Brin MF; Boodhoo TI; Pogoda JM; James LM; Demos G; Terashima Y; Gu J; Eadie N; Bowen BL
    J Am Acad Dermatol; 2009 Dec; 61(6):961-70.e1-11. PubMed ID: 19744746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of OnabotulinumtoxinA for Treatment of Crow's Feet Lines in Chinese Subjects.
    Wu Y; Wang G; Li C; Mao C; Lei X; Lee E
    Plast Reconstr Surg Glob Open; 2019 Jan; 7(1):e2079. PubMed ID: 30859038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OnabotulinumtoxinA for Treatment of Moderate to Severe Crow's Feet Lines: A Review.
    Carruthers A; Bruce S; Cox SE; Kane MA; Lee E; Gallagher CJ
    Aesthet Surg J; 2016 May; 36(5):591-7. PubMed ID: 26979457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-perception of natural outcome, appearance, and emotional well-being after OnabotulinumtoxinA treatment for upper facial lines: Post hoc analysis across age and gender.
    Dayan S; Ogilvie P; Boyd C; De Boulle K; Cavallini M; Garcia JK; Musumeci M
    J Cosmet Dermatol; 2024 Jan; 23(1):107-116. PubMed ID: 37616390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.